2 hr 14 min ago
NOW: CDC advisers meet to discuss how to move forward with J&J vaccine in the US
From CNN's Maggie Fox
Vaccine advisers to the US Centers for Disease Control and Prevention are meeting now to discuss how to move forward with Johnson & Johnson's Janssen coronavirus vaccine.
The Advisory Committee on Immunization Practices is scheduled to meet until to 5 p.m. ET Friday and to vote on updated recommendations for use of the vaccine and whether it's likely to be linked to a rare blood clotting syndrome they are calling thrombosis with thrombocytopenia syndrome (TTS).
Other groups have called it vaccine-induced immune thrombotic thrombocytopenia or VITT, but ACIP is sticking with more neutral language that doesn't presume vaccines are causing the condition.